Answer
No, the safety and efficacy of Lumigan (bimatoprost) have not been established in children aged 0 to less than 18 years.
Sources for this answer
- Lumigan 0.1mg/mlAbbVie Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked